➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Harvard Business School
Johnson and Johnson
Boehringer Ingelheim

Last Updated: June 13, 2021

DrugPatentWatch Database Preview

Patent: 9,974,764

« Back to Dashboard

Summary for Patent: 9,974,764
Title:Compositions and methods of use of phorbol esters in the treatment of neoplasms
Abstract: Methods and compositions containing a phorbol ester or a derivative of a phorbol ester are provided for the treatment of chronic and acute conditions. Such conditions may be caused by disease, be symptoms, treatments, or sequelae of disease. The phorbol esters described are particularly useful in the treatment of neoplastic diseases and/or managing the side effects of chemotherapeutic and radiotherapeutic treatments of neoplastic diseases.
Inventor(s): Han; Zheng Tao (Eugene, OR), Chen; Hung-Fong (Taipei, TW)
Assignee: Biosuccess Biotech Co. Ltd. (Santa Clara, CA)
Application Number:14/026,473
Patent Claims:see list of patent claims

Details for Patent 9,974,764

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Merck ELSPAR asparaginase VIAL 101063 001 1978-01-10   Get Started Free Biosuccess Biotech Co. Ltd. (Santa Clara, CA) 2027-01-31 RX search
Chiron PROLEUKIN aldesleukin VIAL 103293 001 1992-05-05   Get Started Free Biosuccess Biotech Co. Ltd. (Santa Clara, CA) 2027-01-31 RX search
Wyeth Pharms Inc MYLOTARG gemtuzumab ozogamicin VIAL;SINGLE-DOSE 761060 001 2018-04-09   Get Started Free Biosuccess Biotech Co. Ltd. (Santa Clara, CA) 2027-01-31 RX Orphan search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.